Effect of Aripiprazole on Smoking Rate in Male Bipolar Mood Disorder I
- Conditions
- Bipolar Mood Disorder, current episode manic without psychotic feauters.The patient is currently manic, without psychotic symptoms (as in F30.1), and has had at least one other affective episode (hypomanic, manic, depressive, or mixed) in the past.
- Registration Number
- IRCT2016121228173N3
- Lead Sponsor
- Vice chancellor for research, Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria: The definitive diagnosis of bipolar I disorder according to DSM-IV-TR criteria; being in the partial or complete recovery phase based on Yang Mania Rating Scale; having the necessary criteria for diagnosis of nicotine dependence according to DSM-IV-TR criteria; age 18-60 Years old; male gender and consent to attend the study through the signing of informed consent.
?
history of any allergic reaction to drug disorder with respect to Aripiprazole or other anti psychotics; dependence on other substances (based on the patient's history and the outcome of the test of morphine and methamphetamine at the start of the intervention); the use of other drugs used to quit nicotine; Use of medications other than bipolar disorder; history of physical illness (liver failure, renal failure); history of mental retardation; occurrence of any side effects due to Aripiprazole; history of cognitive impairment (dementia).
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Smoking rate (nicotine). Timepoint: before intervention,Six weeks after the intervention. Method of measurement: Fagerstrom Test for Nicotine Dependence (FTQ).
- Secondary Outcome Measures
Name Time Method Side effects of Aripiperazole. Timepoint: First and Fourth Week of Intervention. Method of measurement: Glasgow Antipsychotic Side-effect Scale (GASS).